The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Longitudinal analysis of circulating tumor DNA in localized and metastatic urothelial cancer.
 
Adanma Ayanambakkam
No Relationships to Disclose
 
Anh B. Lam
No Relationships to Disclose
 
Niveditha Popuri
No Relationships to Disclose
 
Laxmi Alekhya Mitta
No Relationships to Disclose
 
Chao Xu
No Relationships to Disclose
 
Sanjay Patel
No Relationships to Disclose
 
Michael Cookson
Honoraria - AstraZeneca/MedImmune; Bayer; Clovis Oncology; FerGene; Lantheus Medical Imaging; MJH Life Sciences; Myovant Sciences; Pacific Edge Biotechnology; Remedica Medical Education & Publishing
Consulting or Advisory Role - Bayer; Janssen Biotech; LynxDx; Myovant Sciences; Nonagen Bioscience; Pfizer; Pfizer; Prokarium; Propella Therapeutics; Signatera
Research Funding - Ferring (Inst); MDxHealth (Inst)
Travel, Accommodations, Expenses - Janssen; Pfizer; Progenics; Progenics
 
Kelly Lynn Stratton
Honoraria - Bayer; Dendreon (Inst); Janssen; Johnson & Johnson/Janssen; Merck; MJH Life Sciences; Oakstone Publishing; Oakstone Publishing (Inst); Sun Pharma; Urology times
Consulting or Advisory Role - AMRO Pharma (Inst); Bayer (Inst); Bayer (Inst); Clovis Oncology (Inst); Dendreon (Inst); Ebix (Inst); Elsevier (Inst); Janssen (Inst); Large Urology Group Practice Association (Inst); Merck (Inst); Myriad Genetics (Inst); Sanofi (Inst)
Speakers' Bureau - Arkansas Urology; Bayer; Bayer Speaker Bureau
Research Funding - Advantage Pharmaceuticals (Inst); Alliance Foundation Trials (Inst); Anchiano (Inst); Astellas ENACT CTA (Inst); Astellas Pharma (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Dendreon (Inst); EMD Serono (Inst); EMD Serono (Inst); Ferring (Inst); Genentech (Inst); Myovant Sciences (Inst); Myriad Genetics (Inst); Myriad Genetics (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Roche/Genentech (Inst); RTOG (Inst); TARIS Biomedical (Inst); TARIS Biomedical (Inst)
Travel, Accommodations, Expenses - Dendreon; Dendreon (Inst); Myriad Genetics
 
Minh Duc Phan
No Relationships to Disclose
 
Shandy Gosnell
No Relationships to Disclose
 
Amber Dawn Kraft Tarantini
No Relationships to Disclose
 
Vineetha Finny
No Relationships to Disclose
 
Jessica Elliott
No Relationships to Disclose
 
Alicia Tyler-Dixon
No Relationships to Disclose
 
Jessica Mayberry
No Relationships to Disclose
 
Ryan David Nipp
No Relationships to Disclose
 
Abdul Rafeh Naqash
Honoraria - NGM Biopharmaceuticals
Consulting or Advisory Role - foundation me
Travel, Accommodations, Expenses - American Society for Radiation Oncology; ASCO; Binacea; Foundation Medicine; Jazz Pharmaceuticals (Inst); Society for Immunotherapy of Cancer
 
Abhishek Tripathi
Consulting or Advisory Role - AADi; Bayer; Deka Biosciences; Exelixis; Gilead Sciences; Seattle Genetics/Astellas
Speakers' Bureau - Sanofi
Research Funding - Aravive (Inst); Corvus Pharmaceuticals (Inst); EMD Serono (Inst)
 
Rana R. McKay
Consulting or Advisory Role - Ambrx; Ambrx; Arcus Biosciences; Astellas Medivation; AstraZeneca; AVEO; Bayer; Blue Earth Diagnostics; Bristol-Myers Squibb; Calithera Biosciences; Caris Life Sciences; Dendreon; Esiai; Exelixis; Janssen; Lilly; Merck; Myovant Sciences; Novartis; Pfizer; Sanofi; Seagen; Sorrento Therapeutics; Sumitomo Pharma Oncology; Telix Pharmaceuticals; Tempus; Vividion Therapeutics
Research Funding - Artera (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol Myers Squibb (Inst); Exelixis (Inst); Oncternal Therapeutics (Inst); Tempus (Inst)